explore -WSS

explore

author：fashion 2025-10-02 13:13:58 - browse：55237

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Trump surgeon general acknowledges mistakes during Covid

hotspot

WSS

STAT Summit: Biotech founders on deal

Humana sues Biden admin over Medicare Advantage audit rule

'Make People Better': The CRISPR babies story you probably don't know

AstraZeneca chief proposes a novel edit to the drug pricing bill

Solve the antibiotic resistance crisis with preventive drugs

How to protect patients from sexual assault

entertainment

explore

explore

Sports medicine is finally prioritizing gender equality

The 10 drugs up first for Medicare price negotiation

State Dept. review finds Biden bears some blame for Afghanistan failures

Researchers explore possible ties between long Covid, menopause

Walensky prepares to leave CDC — and Congress — behind

What American doctors can learn from their Israeli counterparts

Supreme Court strikes down use of affirmative action

Pharmacists can make shortage drugs, but at what cost?

As demand for Covid shots wanes, Moderna seeks its next success

The 10 drugs up first for Medicare price negotiation

focus

Why health workers in Gaza are injured or die at high rates

Why Novartis is changing the name of its research labs

STAT Summit: How a Chicago ER doctor tackles gun violence

Eli Lilly expects to double planned employment in Boston center

'Make People Better': The CRISPR babies story you probably don't know

STAT Summit: Michael J. Fox on progress in Parkinson's research

knowledge

hotspot

hotspot

knowledge